[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL253203A1 - Method of obtaining novel derivatives of 2-oxindolo-1-carbonamide - Google Patents

Method of obtaining novel derivatives of 2-oxindolo-1-carbonamide

Info

Publication number
PL253203A1
PL253203A1 PL25320385A PL25320385A PL253203A1 PL 253203 A1 PL253203 A1 PL 253203A1 PL 25320385 A PL25320385 A PL 25320385A PL 25320385 A PL25320385 A PL 25320385A PL 253203 A1 PL253203 A1 PL 253203A1
Authority
PL
Poland
Prior art keywords
oxindolo
carbonamide
novel derivatives
obtaining novel
obtaining
Prior art date
Application number
PL25320385A
Other versions
PL145416B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL253203A1 publication Critical patent/PL253203A1/en
Publication of PL145416B1 publication Critical patent/PL145416B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL1985253203A 1984-05-04 1985-05-03 Method of obtaining novel derivatives of 2-oxindolo-1-carbonamide PL145416B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
PL253203A1 true PL253203A1 (en) 1986-06-17
PL145416B1 PL145416B1 (en) 1988-09-30

Family

ID=24431933

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1985253203A PL145416B1 (en) 1984-05-04 1985-05-03 Method of obtaining novel derivatives of 2-oxindolo-1-carbonamide
PL1985257892A PL147508B1 (en) 1984-05-04 1985-05-03 Method of obtaining novel derivatives of 2-oxindolo-1-carbonamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1985257892A PL147508B1 (en) 1984-05-04 1985-05-03 Method of obtaining novel derivatives of 2-oxindolo-1-carbonamide

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO91141B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
MW1685A1 (en) 1986-09-10
CS252828B2 (en) 1987-10-15
RO94455A (en) 1988-06-30
CS320285A2 (en) 1987-03-12
SU1468413A3 (en) 1989-03-23
BG60207B2 (en) 1993-12-30
RU2017729C1 (en) 1994-08-15
ZA853324B (en) 1986-12-30
FI80016B (en) 1989-12-29
YU73085A (en) 1988-04-30
IE851103L (en) 1985-11-04
MA20424A1 (en) 1985-12-31
ES8707182A1 (en) 1987-07-16
ES551275A0 (en) 1987-07-16
PT80375B (en) 1987-09-30
NO163132C (en) 1990-04-11
JPS60243068A (en) 1985-12-03
FI80016C (en) 1990-04-10
YU44998B (en) 1991-06-30
RO91141A (en) 1987-06-30
BG60208B2 (en) 1993-12-30
AR241159A2 (en) 1991-12-30
NO163132B (en) 1990-01-02
KR850008154A (en) 1985-12-13
KR870000497B1 (en) 1987-03-12
ES8609248A1 (en) 1986-07-16
DD232916A5 (en) 1986-02-12
HUT37754A (en) 1986-02-28
IN161509B (en) 1987-12-19
MX5839A (en) 1993-11-01
AR241159A1 (en) 1991-12-30
RO91141B (en) 1987-07-03
NO851774L (en) 1985-11-05
PT80375A (en) 1985-05-01
HU196057B (en) 1988-09-28
PL145416B1 (en) 1988-09-30
ZW7885A1 (en) 1985-07-24
ES542813A0 (en) 1986-07-16
PL147508B1 (en) 1989-06-30
JPH0335315B2 (en) 1991-05-27
PL257892A1 (en) 1986-10-07
FI851756A0 (en) 1985-05-03
OA08098A (en) 1987-03-31
EG17193A (en) 1990-08-30
RO94455B (en) 1988-07-01
FI851756L (en) 1985-11-05

Similar Documents

Publication Publication Date Title
PL254207A1 (en) Method of obtaining derivatives of ganglyosides
PL252659A1 (en) Method of obtaining acylotripeptides
PL253246A1 (en) Method of obtaining novel pyrolobenzimidazoles
PL265523A1 (en) Method of obtaining novel derivatives of allanilproline
PL251972A1 (en) Method of obtaining derivatives of pleuromutiline
PL255465A1 (en) Method of obtaining derivatives of 2-ketoindole
PL262327A1 (en) Method of obtaining 2-ketoindolo-3-carbonamides
PL252882A1 (en) Method of obtaining 4-hydroxy-2h-1-benzothiooran-2-ones
PL255499A1 (en) Method of obtaining novel derivatives of quinazolinodione
PL253089A1 (en) Method of obtaining novel derivatives of iminotriazolidine
PL252161A1 (en) Method of obtaining novel salts-derivatives of oxazephorine
PL252433A1 (en) Method of obtaining 2-oxindolo-1-carbonamides
PL257564A1 (en) Method of obtaining novel derivatives of thiocyanopyrimidine
PL251456A1 (en) Method of obtaining derivatives of thioxantene
PL254117A1 (en) Method of obtaining novel derivatives of oxycames
PL253203A1 (en) Method of obtaining novel derivatives of 2-oxindolo-1-carbonamide
PL256441A1 (en) Method of obtaining novel alkylidenedioylic derivatives
PL255588A1 (en) Method of obtaining novel derivatives of iminacetamide
PL252772A1 (en) Method of obtaining novel derivatives of 1-phenylindole
PL254931A1 (en) Method of obtaining novel derivatives of propargiloksyacetnitrile
PL256452A1 (en) Method of obtaining novel derivatives of sulfamylurea
PL247306A1 (en) Method of obtaining novel derivatives of phenyloethanoloamine
PL248295A1 (en) Method of obtaining novel hydrosuccinates being derivatives of 12-oleanen-3 beta-ole
PL247031A1 (en) Method of obtaining o-chlorobenzenoilicyclopentane
PL249993A1 (en) Method of obtaining n-triphenylmethylimidazole